The Zhitong Finance App learned that Chunyu Healthcare (00108) rose by more than 18% in the afternoon. As of press release, it rose 17.99% to HK$2.82, with a turnover of HK$4.922,600.
According to news, in September of this year, Dr. Chunyu, the core platform of Chunyu Medical under Guorui Group, signed a strategic cooperation agreement with the international high-end medical brand Ritz-Carle Group. This cooperation is an important business practice for Dr. Chunyu to open up a closed loop of health management throughout the user life cycle. It is also a key step for Guorui Group to promote the deep integration of “digital healthcare+high-end health+high-end community scenarios”.
At the signing site, Wei Chunxian, chairman of the board of directors of Guorui Group and chairman of Chunyu Medical, said, “The core of the development of the digital medical industry is to enable AI Internet technology to actually implement offline medical scenarios and transform online traffic into real and perceptible medical services. Dr. Chunyu has digital technology, physician resources and a large number of users. Ritz-Carr has a mature physical medical network, accurate diagnosis and treatment, and health service capabilities. The cooperation between the two parties complements the advantages of digital technology and physical medicine. Through this strategic cooperation, Guorui Group hopes to break through online and offline high-end medical services, provide users with consistent and closed-loop health solutions, and promote the high-quality development of the health industry.”